EP 1315507 A2 20030604 - HPV-SPECIFIC SHORT-MERS
Title (en)
HPV-SPECIFIC SHORT-MERS
Title (de)
HPV-SPEZIFISCHE KURZE OLIGOMERE
Title (fr)
OLIGOMERS COURTS SPECIFIQUE AU HPV
Publication
Application
Priority
- US 0140501 W 20010411
- US 19599600 P 20000411
Abstract (en)
[origin: WO0177294A2] The invention provides oligonucleotides capable of inhibiting human papillomavirus (HPV) replication. More specifically, the invention provides oligonucleotides complementary to the translational start site of the HPV E1 open reading frame which inhibit HPV replication through interaction with a nucleic acid or a protein target. Oligonucleotides of the invention contain at least 4 deoxyribonucleotides and/or ribonucleotides and may include a variety of modifications to the internucleotide linkages or the mononucleotides. Furthermore, the invention provides pharmaceutical compositions and methods for treating disorders or diseases associated with HPV infection.
IPC 1-7
C07H 21/02; C07H 21/04; C12N 15/11; A61K 31/7105; A61K 31/711; A61K 31/7125; A61P 31/20
IPC 8 full level
A61K 31/7125 (2006.01); A61K 48/00 (2006.01); A61P 15/00 (2006.01); A61P 17/12 (2006.01); A61P 31/20 (2006.01); A61P 35/00 (2006.01); C07K 14/025 (2006.01); C12N 15/09 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 15/00 (2017.12); A61P 17/12 (2017.12); A61P 31/20 (2017.12); A61P 35/00 (2017.12); C07K 14/005 (2013.01); A61K 38/00 (2013.01); C12N 2710/20022 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0177294 A2 20011018; WO 0177294 A3 20020404; AU 5760401 A 20011023; CA 2406485 A1 20011018; EP 1315507 A2 20030604; EP 1315507 A4 20040616; JP 2004501614 A 20040122
DOCDB simple family (application)
US 0140501 W 20010411; AU 5760401 A 20010411; CA 2406485 A 20010411; EP 01931140 A 20010411; JP 2001575148 A 20010411